T1	Intervention 147 149	GH
T2	Intervention 306 318	GH treatment
T3	Intervention 491 509	placebo-controlled
T4	Intervention 525 632	Urinary steroid profile was used to estimate 11betaHSD type 1 and 2 (11betaHSD1 and 11betaHSD2) activities.
T5	Intervention 633 647	Abdominal s.c.
T6	Intervention 648 717	and visceral adipose tissues were measured using computed tomography.
T7	Intervention 718 847	Glucose disposal rate (GDR) obtained during a euglycaemic-hyperinsulinaemic glucose clamp was used to assess insulin sensitivity.
